The Russian Direct Investment Fund (RDIF), which has financed the development of the vaccine, said it and Shenzhen Yuanxing Gene-tech Co. have agreed to cooperate on production of over 60 million doses of Sputnik in China.
Original source: https://health.economictimes.indiatimes.com/news/pharma/81746263?utm_source=RSS&utm_medium=ETRSS
